Johnson & Johnson said it won US approval for a tiny drug-delivery system to treat bladder cancer, a first-of-its kind product the company expects to bring in blockbuster revenue.

5. The short you do watch has Leonardo DiCaprio (heartthrob of youth) playing the cantankerous father figure to group of ...

5. The short you do watch has Leonardo DiCaprio (heartthrob of youth) playing the cantankerous father figure to group of ...

And why wouldn't you use that information to the full benefit of patients ... We think there's about 400 Pet scanners in the U.S. that have never tasted PSMA. It's about 15% of patients. So there's a ...

Staff and patients at Nevill Hall hospital are benefitting from the donation of new specialist equipment owing to the ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of ...

The FDA has approved Inlexzo for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ.

Johnson & Johnson received Food and Drug Administration approval for Inlexzo, a treatment for people with bladder cancer.

The FDA approves INLEXZO, a groundbreaking treatment for bladder cancer, offering hope for patients unresponsive to traditional therapies.